BDBM707315 US12162878, Compound 217

SMILES Cn5cc(c1cc(S(N)(=O)=O)c(F)cc1N2CCC3(CC2)CC3(F)F)c4C=CCc4c5=O

InChI Key InChIKey=VYNYPLNNLNISCK-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 707315   

TargetBromodomain-containing protein 2(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM707315(US12162878, Compound 217)
Affinity DataIC50: 1.40nMAssay Description:The compounds were screened in vitro, and each compound was serially diluted to 10 concentrations. Four proteins BRD4 (D1+D2), BRDT (D1), BRD2 (D1+D2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/21/2025
Entry Details
US Patent

TargetBromodomain-containing protein 2(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM707315(US12162878, Compound 217)
Affinity DataIC50: 1.5nMAssay Description:The compounds were screened in vitro, and each compound was serially diluted to 10 concentrations. Four proteins BRD4 (D1+D2), BRDT (D1), BRD2 (D1+D2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/21/2025
Entry Details
US Patent

TargetBromodomain-containing protein 3(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM707315(US12162878, Compound 217)
Affinity DataIC50: 4.5nMAssay Description:The compounds were screened in vitro, and each compound was serially diluted to 10 concentrations. Four proteins BRD4 (D1+D2), BRDT (D1), BRD2 (D1+D2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/21/2025
Entry Details
US Patent

TargetBromodomain-containing protein 3(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM707315(US12162878, Compound 217)
Affinity DataIC50: 4.90nMAssay Description:The compounds were screened in vitro, and each compound was serially diluted to 10 concentrations. Four proteins BRD4 (D1+D2), BRDT (D1), BRD2 (D1+D2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/21/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM707315(US12162878, Compound 217)
Affinity DataIC50: 4.90nMAssay Description:The compounds were screened in vitro, and each compound was serially diluted to 10 concentrations. Four proteins BRD4 (D1+D2), BRDT (D1), BRD2 (D1+D2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/21/2025
Entry Details
US Patent

TargetBromodomain-containing protein 4(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM707315(US12162878, Compound 217)
Affinity DataIC50: 6.20nMAssay Description:The compounds were screened in vitro, and each compound was serially diluted to 10 concentrations. Four proteins BRD4 (D1+D2), BRDT (D1), BRD2 (D1+D2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/21/2025
Entry Details
US Patent

TargetBromodomain testis-specific protein(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM707315(US12162878, Compound 217)
Affinity DataIC50: 19nMAssay Description:The compounds were screened in vitro, and each compound was serially diluted to 10 concentrations. Four proteins BRD4 (D1+D2), BRDT (D1), BRD2 (D1+D2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/21/2025
Entry Details
US Patent

TargetBromodomain testis-specific protein(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM707315(US12162878, Compound 217)
Affinity DataIC50: 20nMAssay Description:The compounds were screened in vitro, and each compound was serially diluted to 10 concentrations. Four proteins BRD4 (D1+D2), BRDT (D1), BRD2 (D1+D2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/21/2025
Entry Details
US Patent